Distinct Mechanisms of CD4+ and CD8+ T-Cell Activation and Bystander Apoptosis Induced by Human Immunodeficiency Virus Type 1 Virions
暂无分享,去创建一个
[1] M. Tremblay,et al. Insertion of Host-Derived Costimulatory Molecules CD80 (B7.1) and CD86 (B7.2) into Human Immunodeficiency Virus Type 1 Affects the Virus Life Cycle , 2004, Journal of Virology.
[2] E. De Clercq,et al. Apoptosis of Bystander T Cells Induced by Human Immunodeficiency Virus Type 1 with Increased Envelope/Receptor Affinity and Coreceptor Binding Site Exposure , 2004, Journal of Virology.
[3] T. Chun,et al. Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[4] J. Sodroski,et al. Cytolysis by CCR5-Using Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Is Dependent on Membrane Fusion and Can Be Inhibited by High Levels of CD4 Expression , 2003, Journal of Virology.
[5] E. De Clercq,et al. In Vivo Evolution of Human Immunodeficiency Virus Type 1 toward Increased Pathogenicity through CXCR4-Mediated Killing of Uninfected CD4 T Cells , 2003, Journal of Virology.
[6] J. Sprent,et al. Direct stimulation of naïve T cells by membrane vesicles from antigen-presenting cells: Distinct roles for CD54 and B7 molecules , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. Gougeon,et al. Cell death and immunity: Apoptosis as an HIV strategy to escape immune attack , 2003, Nature Reviews Immunology.
[8] C. Payá,et al. CCR5 mediates Fas- and caspase-8 dependent apoptosis of both uninfected and HIV infected primary human CD4 T cells , 2002, AIDS.
[9] Richard A Lempicki,et al. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Corbeil,et al. Effects of Antiretroviral Drugs on Human Immunodeficiency Virus Type 1-Induced CD4+ T-Cell Death , 2002, Journal of Virology.
[11] M. Lenardo,et al. Cytopathic Killing of Peripheral Blood CD4+ T Lymphocytes by Human Immunodeficiency Virus Type 1 Appears Necrotic rather than Apoptotic and Does Not Require env , 2002, Journal of Virology.
[12] Z. Grossman,et al. CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause? , 2002, Nature Medicine.
[13] Z. Bentwich,et al. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention , 2002, AIDS.
[14] J. Altman,et al. Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells. , 2001, Immunity.
[15] E. De Clercq,et al. HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling. , 2001, Blood.
[16] J. Lifson,et al. Differential Incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and Major Histocompatibility Complex Class I and II Molecules into Human Immunodeficiency Virus Type 1 Virions and Microvesicles: Implications for Viral Pathogenesis and Immune Regulation , 2001, Journal of Virology.
[17] R. Compans,et al. HIV envelope proteins differentially utilize CXCR4 and CCR5 coreceptors for induction of apoptosis. , 2001, Virology.
[18] J. McCune,et al. The dynamics of CD4+ T-cell depletion in HIV disease , 2001, Nature.
[19] W. Greene,et al. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell , 2001, Nature.
[20] Nancy Dumais,et al. Attachment of Human Immunodeficiency Virus-1 (HIV-1) Particles Bearing Host-encoded B7-2 Proteins Leads to Nuclear Factor-κB- and Nuclear Factor of Activated T Cells-dependent Activation of HIV-1 Long Terminal Repeat Transcription* , 2001, The Journal of Biological Chemistry.
[21] J. Lifson,et al. Partial Activation and Induction of Apoptosis in CD4+ and CD8+ T Lymphocytes by Conformationally Authentic Noninfectious Human Immunodeficiency Virus Type 1 , 2001, Journal of Virology.
[22] C. Payá,et al. Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. , 2001, The Journal of clinical investigation.
[23] J. Sodroski,et al. Importance of Membrane Fusion Mediated by Human Immunodeficiency Virus Envelope Glycoproteins for Lysis of Primary CD4-Positive T Cells , 2000, Journal of Virology.
[24] M. Malim,et al. Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding , 2000, Journal of Virology.
[25] H. Schuitemaker,et al. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock , 2000, Nature Immunology.
[26] J. Grivel,et al. Human Immunodeficiency Virus Type 1 Induces Apoptosis in CD4+ but Not in CD8+ T Cells in Ex Vivo-Infected Human Lymphoid Tissue , 2000, Journal of Virology.
[27] N. Oyaizu,et al. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway. , 2000, Blood.
[28] P. Lipsky,et al. Cutting Edge: Stromal Cell-Derived Factor-1 Is a Costimulator for CD4+ T Cell Activation1 , 2000, The Journal of Immunology.
[29] Dzung H. Nguyen,et al. Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts , 2000, Journal of Virology.
[30] I. Chen,et al. Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation , 2000, Journal of Virology.
[31] E. De Clercq,et al. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo. , 1999, The Journal of clinical investigation.
[32] J. Hoxie,et al. Exclusion of HIV coreceptors CXCR4, CCR5, and CCR3 from the HIV envelope. , 1999, AIDS research and human retroviruses.
[33] Wildt,et al. Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. , 1999, Journal of immunology.
[34] R. Osathanondh,et al. Apoptosis Induced by Infection of Primary Brain Cultures with Diverse Human Immunodeficiency Virus Type 1 Isolates: Evidence for a Role of the Envelope , 1999, Journal of Virology.
[35] R. Grunow,et al. CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals. , 1999, Immunology letters.
[36] J. Jason,et al. Increased expression of CD80 and CD86 in in vitro-infected CD3+ cells producing cytoplasmic HIV type 1 p24. , 1999, AIDS research and human retroviruses.
[37] Louis J. Picker,et al. Changes in thymic function with age and during the treatment of HIV infection , 1998, Nature.
[38] J. Paquette,et al. Level of ICAM-1 Surface Expression on Virus Producer Cells Influences both the Amount of Virion-Bound Host ICAM-1 and Human Immunodeficiency Virus Type 1 Infectivity , 1998, Journal of Virology.
[39] P. Gregersen,et al. Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4 , 1998, Nature.
[40] M. Lederman,et al. In vivo analysis of Fas/FasL interactions in HIV-infected patients. , 1998, The Journal of clinical investigation.
[41] C. Payá,et al. The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. , 1998, The Journal of clinical investigation.
[42] C. Payá,et al. CD4 Regulates Susceptibility to Fas ligand– and Tumor Necrosis Factor–mediated Apoptosis , 1998, The Journal of experimental medicine.
[43] M. J. Tremblay,et al. T Cells Expressing Activated LFA-1 Are More Susceptible to Infection with Human Immunodeficiency Virus Type 1 Particles Bearing Host-Encoded ICAM-1 , 1998, Journal of Virology.
[44] A. Moses,et al. The influence of human immunodeficiency virus-1 on hematopoiesis. , 1998, Blood.
[45] C. Van Lint,et al. Distinct Mechanisms Trigger Apoptosis in Human Immunodeficiency Virus Type 1-Infected and in Uninfected Bystander T Lymphocytes , 1998, Journal of Virology.
[46] M. Prevost,et al. Strategies for phenotyping apoptotic peripheral human lymphocytes comparing ISNT, annexin-V and 7-AAD cytofluorometric staining methods. , 1997, Journal of immunological methods.
[47] D. Weissman,et al. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor , 1997, Nature.
[48] E. Clercq,et al. Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4 , 1997, The Journal of experimental medicine.
[49] K. Ikuta,et al. Exposure of resting peripheral blood T cells to HIV-1 particles generates CD25+ killer cells in a small subset, leading to induction of apoptosis in bystander cells. , 1997, International immunology.
[50] S. Uccini,et al. Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy. , 1997, Blood.
[51] M. Tremblay,et al. Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity , 1997, Journal of virology.
[52] M. Tremblay,et al. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity , 1997, Journal of virology.
[53] J. Sodroski,et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia , 1997, Nature.
[54] A. Capron,et al. Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule. , 1997, The Journal of clinical investigation.
[55] K. Ikuta,et al. Protease-defective, gp120-containing human immunodeficiency virus type 1 particles induce apoptosis more efficiently than does wild-type virus or recombinant gp120 protein in healthy donor-derived peripheral blood T cells , 1997, Journal of clinical microbiology.
[56] J. Tschopp,et al. Apoptosis of Fashigh CD4+ Synovial T Cells by Borrelia-reactive Fas-ligandhigh γδ T Cells in Lyme Arthritis , 1996, The Journal of experimental medicine.
[57] H. Katinger,et al. Acquisition of host cell‐surface‐derived molecules by HIV‐1 , 1996, AIDS.
[58] S. Nagata,et al. Fas-mediated apoptosis of CD4+ and CD8+ T cells from human immunodeficiency virus-infected persons: differential in vitro preventive effect of cytokines and protease antagonists. , 1996, Blood.
[59] J. Sodroski,et al. Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1 , 1996, Journal of virology.
[60] S. Zolla-Pazner,et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1 , 1995, The Journal of experimental medicine.
[61] G. Luzi,et al. Frequency of provirus-bearing CD4+ cells in HIV type 1 infection correlates with extent of in vitro apoptosis of CD8+ but not of CD4+ cells. , 1995, AIDS research and human retroviruses.
[62] J. Margolick,et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection , 1995, Nature Medicine.
[63] P. Krammer,et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120 , 1995, Nature.
[64] L. Herzenberg,et al. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals , 1995, The Journal of experimental medicine.
[65] A. Fauci,et al. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. , 1995, Journal of immunology.
[66] M. Roederer,et al. CD8 naive T cell counts decrease progressively in HIV-infected adults. , 1995, The Journal of clinical investigation.
[67] V. Metelev,et al. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. , 1995, Science.
[68] T. Curiel,et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes , 1995, Nature Medicine.
[69] M. Martin,et al. Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1 , 1994, Journal of virology.
[70] P. Linsley,et al. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[71] B. Autran,et al. A Novel Mode of Human Immunodeficiency Virus Type 1 (HIV-1) Activation: Ligation of CD28 Alone Induces HIV-1 Replication in Naturally Infected Lymphocytes , 1993, Journal of Virology.
[72] M. Kieny,et al. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. , 1993, AIDS research and human retroviruses.
[73] P. Sharp,et al. A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. , 1993, Virology.
[74] D. Dimitrov,et al. Quantitation of human immunodeficiency virus type 1 infection kinetics , 1993, Journal of virology.
[75] S. J. Clark,et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. , 1993, Science.
[76] L. Arthur,et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. , 1992, Science.
[77] N. Haigwood,et al. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis , 1992, The Journal of experimental medicine.
[78] F. Miedema,et al. Programmed death of T cells in HIV-1 infection. , 1992, Science.
[79] R. Desrosiers,et al. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[80] M. Emerman,et al. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. , 1991, Virology.
[81] J. Moore,et al. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization , 1991, Journal of virology.
[82] M. Clerici,et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. , 1989, The Journal of clinical investigation.
[83] R. Gallo,et al. Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line. , 1981, Virology.
[84] J. Giguère,et al. New Insights into the Functionality of a Virion-Anchored Host Cell Membrane Protein: CD28 Versus HIV Type 1 , 2002 .
[85] O. Vainio,et al. MHC class II β-chain and αIIbβ3 integrin are expressed on T-cell progenitors in embryonic bone marrow , 2001 .
[86] J. Moore,et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor , 1998, Nature Medicine.
[87] V. Kuchroo,et al. CD28/B7 costimulation: a review. , 1998, Critical reviews in immunology.
[88] D. Vergani,et al. Markers of immune cell activation and disease progression. Cell activation in HIV disease. , 1995, Advances in experimental medicine and biology.